Vadim Ivanov Selected Research

Lenalidomide (CC 5013)

10/2019	Efficacy and safety of autologous stem cell transplantation after induction therapy with lenalidomide, bortezomib, and dexamethasone.
11/2014	Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
9/2010	Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vadim Ivanov Research Topics

Disease

23	Neoplasms (Cancer) 07/2023 - 01/2004
11	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2005
4	Infections 01/2021 - 01/2008
4	Melanoma (Melanoma, Malignant) 01/2013 - 01/2006
3	Lymphoma (Lymphomas) 01/2020 - 11/2014
3	Breast Neoplasms (Breast Cancer) 01/2013 - 01/2005
3	Osteosarcoma (Osteogenic Sarcoma) 01/2006 - 02/2005
2	Multiple Myeloma 10/2019 - 01/2018
2	Atherosclerosis 07/2010 - 05/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2006 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2005 - 01/2004
1	COVID-19 02/2022
1	Plasmablastic Lymphoma 04/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Sepsis (Septicemia) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Heart Failure 03/2016
1	Frailty 03/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Myocardial Infarction 01/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	Angina Pectoris 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014
1	Necrosis 01/2013
1	Hodgkin Disease (Hodgkin's Disease) 07/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2012
1	Virus Diseases (Viral Diseases) 05/2011
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2010
1	Aortic Dissection 05/2010

Drug/Important Bio-Agent (IBA)

20	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2013 - 01/2004
19	Proline (L-Proline)FDA Link 01/2007 - 01/2004
19	Lysine (L-Lysine)FDA Link 01/2007 - 01/2004
18	TeaIBA 03/2010 - 01/2005
17	Arginine (L-Arginine)FDA Link 01/2007 - 01/2004
17	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 01/2004
12	matrigelIBA 01/2007 - 01/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 01/2005
6	Antineoplastic Agents (Antineoplastics)IBA 01/2007 - 01/2004
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
4	GelatinasesIBA 10/2006 - 01/2005
4	Therapeutic UsesIBA 04/2006 - 01/2005
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2006 - 01/2004
4	Fibronectins (Fibronectin)IBA 01/2006 - 01/2005
3	Lenalidomide (CC 5013)FDA Link 10/2019 - 09/2010
3	Rituximab (Mabthera)FDA Link 11/2014 - 09/2010
3	MucinsIBA 01/2006 - 01/2005
3	Methylnitronitrosoguanidine (MNNG)IBA 01/2006 - 02/2005
2	VaccinesIBA 02/2022 - 05/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 09/2010
2	Peptides (Polypeptides)IBA 06/2018 - 05/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2007
2	nilotinib FDA Link 01/2015 - 01/2011
2	EnzymesIBA 05/2011 - 01/2006
2	Angiotensin IIIBA 07/2010 - 05/2010
2	Apolipoproteins E (ApoE)IBA 07/2010 - 05/2010
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2010 - 01/2005
2	Bovine Serum AlbuminIBA 01/2007 - 04/2006
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2006 - 02/2005
2	Penicillins (Penicillin)FDA Link 04/2006 - 10/2005
2	Streptomycin (Streptomycin Sulfate)FDA Link 04/2006 - 10/2005
1	CPX-351IBA 07/2023
1	lutetium Lu 177 dotatateIBA 07/2023
1	daratumumabIBA 04/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Respiratory Syncytial Virus VaccinesIBA 01/2021
1	blinatumomabIBA 01/2020
1	Bortezomib (Velcade)FDA Link 10/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	SodiumIBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	CalciumIBA 01/2016
1	Nifedipine (Adalat)FDA LinkGeneric 01/2016
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 01/2016
1	PalmitatesIBA 01/2016
1	HomoharringtonineIBA 01/2015
1	Dasatinib (BMS 354825)FDA Link 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 01/2013
1	CytokinesIBA 01/2013
1	gulonolactoneIBA 01/2013
1	Monoclonal AntibodiesIBA 06/2012
1	Heme (Haem)IBA 05/2011
1	Immunoglobulins (Immunoglobulin)IBA 05/2011
1	QuercetinIBA 03/2010
1	CaspasesIBA 10/2008

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2018 - 01/2005
5	Therapeutics 07/2023 - 01/2007
3	Transplantation 07/2023 - 07/2012
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Catheters 03/2016
1	Salvage Therapy 07/2012
1	Stem Cell Transplantation 07/2012
1	Intraperitoneal Injections 03/2010